Clinical Trials Logo
  1. Home
  2. Gastrointestinal Cancer
  3. NCT05788874
  4. Details
NCT05788874 Clinical Trial

Study of 18F-FAPI Applied to Gastrointestinal Cancer

Gastrointestinal Cancer Clinical Trial

Official title:
Comparative Study of 18F-FAPI and 18F-FDG PET/CT for Gastrointestinal Cancer

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05788874
Other study ID # XJTU1AF-CRF-2022-021
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 2023
Est. completion date December 2024

Study information
Verified date April 2023
Source First Affiliated Hospital Xi'an Jiaotong University
Contact Yan Li
Phone 0086-15829364429
Email 29396779@qq.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Comparison of tumor volume, number, and SUVmax of different primary foci (gastric, duodenal, and colon cancer), lymph node metastases (neck and supraclavicular, mediastinal, abdominal, and pelvic), and distant metastases (brain, lung, liver, bone, pleura, and peritoneum) detected by 18F-FAPI versus 18F-FDG PET/CT imaging.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 50
Est. completion date December 2024
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Patients with high clinical suspicion of gastrointestinal tumor and negative 18F-FDG at first diagnosis - Post-treatment patients with high clinical suspicion of recurrence or metastasis and negative 18F-FDG Exclusion Criteria: - The diagnosis can be clarified by 18F-FDG PET/CT examination - The presence of recurrence or metastasis can be clarified by 18F-FDG PET/CT examination

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• 18F-FAPI and 18F-FDG PET/CT
18F-FAPI and 18F-FDG PET/CT for gastrointestinal cancer

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
First Affiliated Hospital Xi'an Jiaotong University

Outcome
Type Measure Description Time frame Safety issue
Primary SUVmax Measurement of the maximum standardized uptake value of the lesion 1 day (During the inspection)
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Not yet recruiting NCT05044312 - Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis N/A
Active, not recruiting NCT05053191 - Advancing Nursing Practices in Hospital Oncology Care N/A
Completed NCT03611309 - Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members N/A
Recruiting NCT03602677 - Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage N/A
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Not yet recruiting NCT06398314 - Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors N/A
Withdrawn NCT04030624 - Remote Electronic Patient Monitoring in Gastrointestinal Cancer N/A
Completed NCT02222259 - A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients N/A
Completed NCT02140593 - The Laparotomy Study Phase 4
Active, not recruiting NCT00716209 - Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers N/A
Recruiting NCT01484444 - Biomarker Analysis of Gastrointestinal Cancer N/A
Completed NCT02130427 - A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy N/A
Active, not recruiting NCT00710632 - Screening to Predict Weight Loss in Patients With Cancer N/A
Completed NCT00094965 - Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function Phase 2
Terminated NCT04077372 - Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers N/A
Recruiting NCT04899908 - Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases Phase 2
Recruiting NCT05429866 - Immunological Variables Associated to ICI Toxicity in Cancer Patients Phase 2
Recruiting NCT05226221 - Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality
Recruiting NCT03286348 - Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer N/A